Patent · US Active

Rapid-acting insulin formulation comprising a substituted anionic compound

US10881716B2 · kind B2 · utility

1Cited by
45References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2020
Grant dateJan 5, 2021
Priority date—
Expiry dateApr 14, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08B37/0021
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition in aqueous solution includes insulin and at least one substituted anionic compound chosen from substituted anionic compounds consisting of a backbone formed from a discrete number u of between 1 and 8 (1≤u≤8) of identical or different saccharide units, linked via identical or different glycoside bonds, the saccharide units being chosen from the group consisting of hexoses, in cyclic form or in open reduced form, said compound comprising partially substituted carboxyl functional groups, the unsubstituted carboxyl functional groups being salifiable. A pharmaceutical formulation including the composition is also set forth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.